Basmisanil

From WikiMD's Wellness Encyclopedia

Basmisanil (also known as RG-1662 and RO5186582) is an experimental drug candidate for the treatment of cognitive impairment associated with Down syndrome. It is being developed by Roche and is currently in Phase II clinical trials.

Mechanism of Action[edit | edit source]

Basmisanil is a negative allosteric modulator of the alpha-5 subunit of the GABA-A receptor. It is hypothesized to work by reducing the excessive inhibition in the brains of individuals with Down syndrome, thereby improving cognitive function.

Clinical Trials[edit | edit source]

Basmisanil has undergone Phase I and II clinical trials. The Phase II trial, conducted by Roche, aimed to assess the safety, tolerability, and efficacy of the drug in individuals with Down syndrome aged between 12 and 30 years. However, the results of the trial, published in 2020, showed that Basmisanil did not meet its primary endpoint of improving cognitive function.

Future Development[edit | edit source]

Despite the disappointing results of the Phase II trial, research into the potential benefits of Basmisanil continues. Roche has stated that they remain committed to exploring new treatment options for individuals with Down syndrome.

See Also[edit | edit source]

References[edit | edit source]

Basmisanil Resources
Wikipedia
WikiMD
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD